News Snapshot:
Another Chinese adenovirus vector COVID-19 vaccine ready for human trials By Xinhua News Agency One more Chinese adenovirus vector vaccine candidate against COVID-19 is ready for human trials at home and abroad, its developers said Monday. Researchers from Tsinghua University, Tianjin Medical University and Kunming-based Walvax Biotechnology Co., Ltd. have started developing the vaccine since the outbreak of the epidemic. Compared with other candidates, it was produced using chimpanzee blood. Because there is generally no pre-stored neutralizing antibody against chimpanzee adenovirus in the human body, the vaccine with this virus as the carrier will have the advantages of low adverse...
